Abstract:Abstract Background and Aims A new eGFR equation using serum creatinine (CKD-EPI 2021) without race were developed by Chronic Kidney Disease Epidemiology Collaboration in 2021. We projected the changes of eGFR, CKD prevalence, and incidence of end stage renal disease (ESRD) and mortality in a large prospective cohort of adult Koreans who had voluntary health check-ups, using current (CKD-EPI 2009) and new equation (CKD-EPI 2021). Method We included 112,772 adult participants, aged 18 years or older, who had voluntary routine health check-ups including serum creatinine at three medical centers in Korea from 2003 to 2009. We compared the difference of eGFR and predictability of mortality and ESRD between eGFR values calculated by CKD-EPI 2009 and CKD-EPI 2021. Serum creatinine was expressed as the IDMS-traceable creatinine according to the manufacturer's conversion formula from the original value measured by the alkaline picrate Jaffe kinetic method. The incidence of mortality data was extracted from Statistics Korea and the ESRD data from the ESRD registry of the Korean Society of Nephrology. Results At baseline study, there were 60,723 males (53.8%). Age was 48.9 ± 12.0 years. The value of IDMS-traceable serum creatinine was 0.86 ± 0.21 mg/dl. Levels of eGFR at baseline study were 93.5 ± 15.6 ml/min/1.73 m2 by CKD-EPI2009, and 97.1 ± 15.0 ml/min/1.73 m2 by CKD-EPI2021. Values subtracted eGFRs by CKD-EPI2009 from eGFR by CKD-EPEI2021 were 3.6 ± 1.2 (range: -32.9∼6.1) ml/min/1.73 m2. The difference of eGFR was higher in males compared to females (p<0.001), was the highest in the oldest group among patients aged 18–44 years, 45–64 years, and 65 years or more (p<0.001). Patients with diabetes mellitus (DM) or hypertension showed higher difference of eGFR compared patients without DM or hypertension, respectively (each p<0.001). Patients with eGFR ≥120.0 ml/min/1.73 m2 by CKD-EPI 2009 showed the highest difference between two eGFRs compared to patients with the other values. CKD stage was improved in 11,828 (10.5%) participants using eGFR calculated by CKD-EPI 2021 instead of CKD-EPI 2009, however, only 0.63% of participants with eGFR <60 ml/min/1.73 m2 by CKD-EPI equation was reclassified into eGFR ≥60 ml/min/1.73 m2 by CKD-EPI 2021.During 11.6 ± 2.0 years, 3354 (3.00%) subjects were dead and 151 (0.13%) subjects had end stage renal disease (ESRD) before death. Any eGFR or stage of eGFR was an independent risk factors to ESRD or mortality estimated by Cox's hazard proportional model adjusted by related factors. AUC to estimate renal survival by eGFRs was not different between eGFRs by CKD-EPI2021 and CKD-EPI2009 [0.739 (0.687-0.790) vs 0.740(0.688-0.792), p = 0.170]. p<0.001]. AUC to estimate survival by eGFRs calculated through CKD-EPI equation was slightly higher than that by CKD-EPI2021 equation [0.673(0.664-0.682) vs 0.667(0.658-0.676), p<0.001], however, the difference of AUC was negligible [standard error of AUC difference by two eGFRs; 0.96 (95% CI; 0.006-0.007)]. Conclusion The eGFR calculated by CKD-EPI2021 was higher compared to eGFR calculated by CKD-EPI2009. The power to estimate renal survival was not different between eGFRs by CKD-EPI2021 and CKD-EPI2009.

Comparisons between the 2012 New CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Equations and Other Four Approved Equations

Full Age Spectrum Equation May Be an Alternative Method to Estimate the Glomerular Filtration Rate in Chinese Patients with Chronic Kidney Disease .

Comparison of the 2021 and 2009 Chronic Kidney Disease Epidemiology Collaboration Creatinine equation for estimated glomerular filtration rate in a Chinese population

Revised Equations to Estimate Glomerular Filtration Rate from Serum Creatinine and Cystatin C in China

CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations

Comparison between the Beta-2 Microglobulin-Based Equation and the CKD-EPI Equation for Estimating GFR in CKD Patients in China: ES-CKD Study

Collaboration equation for estimating glomerular fi ltration rate in the Chinese population

Prospective Comparison of Equations Based on Creatinine and Cystatin C for the Glomerular Filtration Rate Estimation in Chinese Renal Transplant Recipients.

Validation Study of Chronic Kidney Disease Epidemiology Collaboration Predictive Equations Based on Serum Creatinine and Cystatin C in Chinese Chronic Kidney Disease Patients

CKD-EPI and EKFC GFR Estimating Equations: Performance and Other Considerations for Selecting Equations for Implementation in Adults

The CKD-EPI 2021 Equation and Other Creatinine-Based Race-Independent eGFR Equations in Chronic Kidney Disease Diagnosis and Staging

Assessment of the 2023 European Kidney Function Consortium (EKFC) equations in a Chinese adult population

Validation of the EKFC equation for glomerular filtration rate estimation and comparison with the Asian-modified CKD-EPI equation in Chinese chronic kidney disease patients in an external study

#3619 CKD EPI 2021 EQUATION FOR EGFR HAS GOOD EFFICACY TO PREDICT CLINICAL OUTCOMES IN A LARGE PROSPECTIVE COHORT OF ADULT KOREANS

Validation of the European Kidney Function Consortium Equation in Chinese Adult Population: An Equation Standing on the Shoulders of Predecessors

Evaluation of the Chronic Kidney Disease Epidemiology Collaboration Equation for Estimating Glomerular Filtration Rate in the Chinese Population

Better Prediction of Clinical Outcome with Estimated Glomerular Filtration Rate by CKD-EPI 2021

Comparison of the performance of currently used estimated glomerular filtration rate equations with 24-hour urine creatinine clearance: sample analysis of randomised controlled trial participants

Comparisons of GFR estimation using the CKD Epidemiology Collaboration (CKD-EPI) equation and other creatinine-based equations in Asian population: a systematic review

Diagnostic Accuracy of Various Glomerular Filtration Rates Estimating Equations in Patients with Chronic Kidney Disease and Diabetes

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.